Home > Insider Trading > Filing (0001073397-20-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
883984	Icu Medical Inc	ICUI	Surgical & Medical Instruments & Apparatus (3841)	330022692

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1073397	A George Lopez	951 Calle Amanecer San Clemente CA 92673		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-28	6,438	$43.62	346,202	No	4	X	Direct
Common Stock	Disposition	2020-05-28	16,548	$197.37	329,654	No	4	S	Direct
Common Stock	Disposition	2020-05-28	3	$198.09	329,651	No	4	S	Direct
Common Stock	Acquisiton	2020-05-28	10,113	$46.53	339,764	No	4	X	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	X	Direct
No	4	S	Direct
No	4	S	Direct
No	4	X	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-05-28	6,438	$43.62	6,438	$43.62
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-05-28	10,113	$46.53	10,113	$46.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-07-20	No	4	X	Direct
78,744		2022-02-01	No	4	X	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	986,843	Indirect	by Partnership

Footnotes

The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $197.00 to $197.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
All shares sold were sold at the exact price disclosed.
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.